Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27266,972,1.20 [1.08-1.34],0.0011648721300139
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26772,2704,1.18 [1.10-1.26],2.4742766157071507e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27018,2040,1.13 [1.05-1.22],0.0017500052605349
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27342,983,1.23 [1.11-1.38],0.0001728068616531
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25440,601,1.34 [1.17-1.54],2.921549827542508e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20536,1185,1.22 [1.11-1.35],7.969105169600207e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25446,276,1.51 [1.24-1.84],4.189205963820105e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27501,1142,1.25 [1.13-1.39],1.3228339696611083e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26882,588,1.29 [1.12-1.48],0.000413565288189
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27549,689,1.19 [1.04-1.36],0.0098430836317375
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27553,168,1.51 [1.18-1.94],0.0012912382539921
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27538,153,1.52 [1.17-1.98],0.0016845007575416
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26622,328,1.33 [1.11-1.61],0.0023868574656157
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26437,78,1.66 [1.16-2.38],0.0055143906695894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Carcinoma in situ of breast,13139,87,0.54 [0.35-0.84],0.0055131939848539
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13187,100,0.57 [0.38-0.85],0.0060311780984524
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",23902,31,3.95 [2.76-5.66],7.7783722748743e-14
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lymphoid leukaemia,23900,29,4.12 [2.94-5.78],2.289223327765885e-16
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26851,2216,1.14 [1.06-1.23],0.0006072985128316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27202,1019,1.20 [1.07-1.34],0.0011473481732644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27202,1019,1.20 [1.07-1.34],0.0011473481732644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27362,924,1.18 [1.06-1.33],0.0039417316190666
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,23760,208,1.37 [1.09-1.74],0.0080359879722018
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25728,136,1.47 [1.12-1.94],0.0057213433898276
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,23738,186,1.52 [1.19-1.93],0.000709560878945
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,23616,64,1.73 [1.18-2.55],0.0052183660950863
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25937,2385,1.27 [1.19-1.37],1.8414860620283088e-11
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,23939,387,1.36 [1.14-1.61],0.0005023188718962
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27217,1307,1.15 [1.04-1.27],0.0048405489815105
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",23939,387,1.26 [1.06-1.51],0.0091728914120432
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,23850,298,1.31 [1.07-1.59],0.0083477625185231
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26961,3409,1.23 [1.16-1.30],8.801508409725957e-12
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24441,889,1.25 [1.11-1.40],0.0001442612143373
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",23683,131,1.55 [1.16-2.06],0.002968446705512
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25868,119,1.50 [1.11-2.03],0.0077464922501984
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1653,37,2.03 [1.32-3.13],0.0013735689017016
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27226,1477,1.26 [1.15-1.38],3.312104151578546e-07
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23960,408,1.25 [1.06-1.49],0.0090325608747939
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26971,104,1.54 [1.12-2.11],0.0074095029734484
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26931,1355,1.27 [1.15-1.39],6.900067077470466e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25705,5998,1.12 [1.07-1.17],1.6511372886287954e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,26277,4884,1.13 [1.07-1.19],2.4102014922257675e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26293,4900,1.13 [1.07-1.19],1.985556035850356e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21455,62,1.74 [1.19-2.55],0.0042336302912975
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,27543,689,1.19 [1.04-1.36],0.0095465510945771
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27086,1500,1.23 [1.12-1.34],7.312411400134692e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26072,486,1.25 [1.07-1.47],0.0044722698065763
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27205,159,1.45 [1.11-1.89],0.0059101722361462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27045,204,1.47 [1.17-1.85],0.001066357510835
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,26895,3673,1.10 [1.04-1.17],0.0010331125542689
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,27111,1524,1.15 [1.05-1.26],0.0020930640534873
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24989,1767,1.15 [1.06-1.25],0.000921325954253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26005,82,1.73 [1.23-2.44],0.0018212154114032
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27039,1116,1.21 [1.09-1.34],0.0003642446802145
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,26219,3055,1.11 [1.04-1.19],0.0009820133573836
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1660,44,2.15 [1.46-3.19],0.0001180872826286
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27604,224,1.37 [1.10-1.72],0.0052439787610888
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27469,253,1.36 [1.10-1.68],0.0047541959270393
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27238,115,1.50 [1.10-2.03],0.0093348465696783
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25747,4243,1.10 [1.05-1.17],0.0003135292968792
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Emphysema,24642,187,1.40 [1.10-1.79],0.0072357414378015
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27465,1190,1.16 [1.05-1.28],0.0041736648367474
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,27472,1225,1.21 [1.10-1.34],0.0001632518490916
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27566,840,1.28 [1.13-1.44],5.294649763051072e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,26825,578,1.21 [1.05-1.40],0.0094751339474894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27385,226,1.38 [1.10-1.72],0.0049328932740843
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27550,391,1.28 [1.08-1.52],0.0048131808102222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27379,220,1.37 [1.09-1.72],0.0060803158037738
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26615,139,1.50 [1.14-1.98],0.0036095998131345
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26336,322,1.29 [1.07-1.56],0.0072691745117176
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24753,612,1.23 [1.07-1.41],0.0042360399168822
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26234,1563,1.15 [1.05-1.25],0.0023820124554064
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26556,2415,1.11 [1.03-1.19],0.0051141505920056
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27082,846,1.29 [1.15-1.45],2.3265411146226387e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26931,695,1.20 [1.05-1.36],0.0082066027456162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dialysis,26297,61,1.72 [1.15-2.56],0.0078446910373843
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27494,71,1.91 [1.35-2.70],0.0002603858859674
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27442,1518,1.16 [1.06-1.27],0.0010326775296379
